erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the..
.
.
�we have waited a long time and we cannot possibly wait any longer.�.
.
.
the staff's "dearth of knowledge" about the correct procedure to follow when someone dies unexpectedly was also highlighted...